Beckman Coulter moves up to No 3 with $800m Olympus' diagnostics buy
This article was originally published in Clinica
Executive Summary
Biomedical tests and labs systems manufacturer Beckman Coulter today announced that it will acquire the lab-based diagnostics business of Olympus' Life Sciences business for ¥77.45bn ($800m).